Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Tuberculosis
Interventions
BIOLOGICAL

BCG

BCG Vaccine USP attenuated live culture for percutaneous use (Merck) at 1-8 x 10\^8 CFUs.

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Rochester

OTHER

lead

Aeras

OTHER